Sofinnova News http://209.237.161.91 Sofinnova News en Copyright 2008 Thu, 02 Feb 2012 00:00:00 +0800 http://www.php.net/ http://blogs.law.harvard.edu/tech/rss <![CDATA[Preglem PEARL I and II studies published in New England Journal of Medicine]]> http://www.preglem.com/files/newspdf/2012-02-02-%20NEJM%20-%20PEARL%20I%20and%20II%20Publications.pdf

]]> http://www.preglem.com/files/newspdf/2012-02-02-%20NEJM%20-%20PEARL%20I%20and%20II%20Publications.pdf http://www.preglem.com/files/newspdf/2012-02-02-%20NEJM%20-%20PEARL%20I%20and%20II%20Publications.pdf Thu, 02 Feb 2012 00:00:00 +0800 <![CDATA[VCs Eye Bargain IPOs as Option for New Investment]]> http://209.237.161.91/uploads/news427.pdf http://209.237.161.91/uploads/news427.pdf Mon, 30 Jan 2012 00:00:00 +0800 <![CDATA[Trius Earns $5 Million Milestone Payment From Bayer for Successful Completion of First Phase 3 Trial of Tedizolid ]]> http://investor.triusrx.com/releasedetail.cfm?ReleaseID=641465

]]> http://investor.triusrx.com/releasedetail.cfm?ReleaseID=641465 http://investor.triusrx.com/releasedetail.cfm?ReleaseID=641465 Mon, 23 Jan 2012 00:00:00 +0800 <![CDATA[Pfizer Initiates Phase 1 Clinical Trial For Fviia Hemophilia Drug Candidate Developed By Catalyst Biosciences IND Filing and Phase 1 Clinical Trial Initiation Trigger Milestone Payments to Catalyst]]> http://www.catalystbiosciences.com/documents/Pfizer-CatalystFVIIaP1InitiationPR5Jan12.pdf

]]> http://www.catalystbiosciences.com/documents/Pfizer-CatalystFVIIaP1InitiationPR5Jan12.pdf http://www.catalystbiosciences.com/documents/Pfizer-CatalystFVIIaP1InitiationPR5Jan12.pdf Thu, 05 Jan 2012 00:00:00 +0800 <![CDATA[Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline]]> http://investor.millennium.com/phoenix.zhtml?c=80159&p=irol-newsarticle&ID=1641428

]]> http://investor.millennium.com/phoenix.zhtml?c=80159&p=irol-newsarticle&ID=1641428 http://investor.millennium.com/phoenix.zhtml?c=80159&p=irol-newsarticle&ID=1641428 Tue, 20 Dec 2011 00:00:00 +0800